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Abstract: Prebiotic oligosaccharides are used to modulate enteric pathogens and reduce pathogen
shedding. The interactions with prebiotics that alter Listeria monocytogenes infection are not yet clearly
delineated. L. monocytogenes cellular invasion requires a concerted manipulation of host epithelial
cell membrane receptors to initiate internalization and infection often via receptor glycosylation.
Bacterial interactions with host glycans are intimately involved in modulating cellular responses
through signaling cascades at the membrane and in intracellular compartments. Characterizing the
mechanisms underpinning these modulations is essential for predictive use of dietary prebiotics
to diminish pathogen association. We demonstrated that human milk oligosaccharide (HMO)
pretreatment of colonic epithelial cells (Caco-2) led to a 50% decrease in Listeria association,
while Biomos pretreatment increased host association by 150%. L. monocytogenes-induced gene
expression changes due to oligosaccharide pretreatment revealed global alterations in host signaling
pathways that resulted in differential subcellular localization of L. monocytogenes during early infection.
Ultimately, HMO pretreatment led to bacterial clearance in Caco-2 cells via induction of the unfolded
protein response and eIF2 signaling, while Biomos pretreatment resulted in the induction of host
autophagy and L. monocytogenes vacuolar escape earlier in the infection progression. This study
demonstrates the capacity of prebiotic oligosaccharides to minimize infection through induction of
host-intrinsic protective responses.
Keywords: prebiotic oligosaccharide; human milk oligosaccharide; eIF2 signaling; unfolded protein
response; ER stress; autophagy; cell-mediated immunity (CMI); c-di-AMP
1. Introduction
Listeria monocytogenes is an intracellular, foodborne, enteric pathogen that is pervasive in livestock,
the food supply and the environment. The most at risk populations include children, pregnant women
and the elderly. Infection begins with febrile gastroenteritis followed by progression to septicemia,
meningitis, or death in immunocompromised individuals and neonatal meningitis or loss of the fetus in
pregnant women [1]. Among the major foodborne pathogen-related illnesses, listeriosis presents with
the highest mortality rate of any foodborne pathogens [2]. Upon invasion of the intestinal epithelial
cell layer, L. monocytogenes reside in an intracellular vacuole, followed by vacuolar escape where the
organism spreads to neighboring cells parallel to the basal lateral membrane [3]. Left unchecked,
infection leads to cell death via apoptosis [4,5].
The molecular basis of Listeria pathogenesis is well understood with the identification of
E-cadherin as the main receptor for host cell entry and actin comet tails as the mechanism of
cell-to-cell dissemination [3]. Transcription profiling during host infection followed by functional
characterization reveals novel gene networks controlled by PrfA, lineage-specific transcriptional
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differences and metabolic network responses to bactericidal treatments [6–8]. During Listeria infection,
listeriolysin O (LLO)-mediated vacuolar escape leads to the host induction of the unfolded protein
response (UPR), repression of eIF2 signaling and subsequent endoplasmic reticulum (ER) stress [9,10]
in the epithelial cell.
In an effort to minimize the costly gastrointestinal infections and antibiotic abuse,
oligosaccharide-based prebiotics are widely used for livestock and human consumption to
prevent gastrointestinal pathogen infections [11]. Prebiotic oligosaccharides, such as yeast-derived
mannan-oligosaccharides (Biomos) and plant-derived inulin, are composed of repeating chains
of a single species of simple carbohydrate monomers connected by a limited repertoire of glycan
linkages [12] that are not readily digested by humans. Unlike plant or yeast-derived oligosaccharides,
human milk oligosaccharides (HMO) are structurally diverse and comprised of various carbohydrates
joined by a variety of chemical linkages [13]. HMO comprise 1–2% of human breast milk composition
and is claimed to selectively promote Bifidobacterium growth while minimizing pathogen association
to neonates [14–16]. While not digestible by mammals, prebiotic oligosaccharides can be utilized by
and interact with, bacteria in the gut that possess glycosyl hydrolases to digest these compounds such
that species-specific interactions and cross feeding occurs between members of the microbiome [17,18].
Prebiotic oligosaccharides are thought to work by acting as host glycan receptor decoys to prevent
pathogen association or by binding to glycan receptors on the host cell to alter the host membrane
composition, thereby physically impeding pathogen entry [19–21]. Conclusive evidence is lacking to
demonstrate the specific mechanism to alter food pathogenic bacteria association.
Despite the importance of glycans in cell-to-cell signaling, the role of glycans in gastrointestinal
host-pathogen interactions remains a burgeoning area of research due to the complex interplay between
microbiota-driven glycan metabolism and host cell signaling [22]. While glycosylation of lipid and
wall teichoic acids mediates L. monocytogenes virulence, little is known about the role of host and
dietary glycans in preventing L. monocytogenes infection or in altering infection progression [23,24].
Glycosylation of soluble bioactive molecules can reduce pathogen shedding and direct bacterial host
association beyond that of the foundational protein [25–27]. Despite identification of E-cadherin as
a primary host receptor in L. monocytogenes internalization, the effect of E-cadherin glycosylation on
L. monocytogenes internalization remains unknown [28,29]. Given the diversity of glycans encountered
by gut pathogens, we hypothesized that prebiotic oligosaccharides altered Listeria host association via
modulation of host signaling pathways [30].
Prebiotics are commonly used to modify the intestinal microbiome composition but little
is known regarding the effect of prebiotics during infection with an enteric pathogen, such as
L. monocytogenes. As a whole, bacteria will preferentially metabolize free, fermentable sugars before
complex carbohydrates, such as prebiotic oligosaccharides, likely allowing prebiotics to reach the
colon in a similar form to which they were consumed. This raises the possibility that prebiotics may to
encounter the host epithelium prior to pathogen infection. This guided the experimental design of this
study to examine the effect of intact oligosaccharides at pharmaceutically-relevant concentrations on
L. monocytogenes infection by pre-treating the host prior to infection. This approach provided the basis
to test several hypotheses that examined specifics of the molecular mechanisms of prebiotic blocking
to reduce pathogen infection, prebiotic-specific host changes and the explicit interaction between
prebiotics and Listeria to manipulate the host response.
In this study, we characterized the effect of host pretreatment with prebiotics on Listeria infectivity
as well as the effects of HMO and mannanoligosaccharides on host (Caco-2) and L. monocytogenes
gene expression during infection of intestinal epithelial monolayers. This led to identification of
the prebiotic mechanism of action against L. monocytogenes host association that was unexpectedly
different between the two oligosaccharides. Listeria infection alone induces host stress responses,
such as the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress. Only HMO
treatment reduced L. monocytogenes infection in vitro. Listeria infection with HMO pretreatment led
to a protective induction of eIF2 signaling, the UPR and subsequent bacterial clearance. In contrast,
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Listeria infection with Biomos pretreatment led to the repression of protective host responses with
a concurrent induction of host autophagy.
2. Results
2.1. HMO Pretreatment Reduces L. monocytogenes Host Invasion
Pathogen blocking capabilities of mannanoligosaccharides (Actigen and Biomos), inulin (Raftilene)
and HMO (UC Davis) were tested in vitro during L. monocytogenes infection of differentiated Caco-2
monolayers. Of the four prebiotics examined, HMO was the only prebiotic that significantly (p < 0.05)
decreased L. monocytogenes in vitro host association. Pretreatment of Caco-2 monolayers with the
mannanoligosaccharides and inulin resulted in a 150% increase in Listeria host association compared to
the untreated control (Figure 1). Based on these observations, we hypothesized that oligosaccharides
have differential effects on the bacterial interactions with the host so as to reduce the bacterial load at
the epithelial membrane. To address this, we visualized the impact of initial differential interactions
on intracellular progression of L. monocytogenes infection.
2.2. Prebiotics Modify L. monocytogenes Infection Dynamics
Due to the observed decrease in host association (Figure 1), we hypothesized that HMO reduced
host association via physical blocking mechanism. To test this hypothesis, we initially visualized
infected cells with transmission electron microscopy (TEM) using a time course during the infection
process. Neither treatment reduced the bacterial association at the membrane but rather changed
bacterial localization during the experiment. Biomos-treated cells displayed vacuolar escape within
20 min post infection (p.i.), rather than reduced association. Conversely, Listeria infected untreated
Caco-2 cells and HMO pretreated cells resulted in vacuoles containing Listeria near the apical side of
infected host cells after 20 min (Figure 2A–C). At 40 min p.i., we observed L. monocytogenes to laterally
infect neighboring cells in Biomos pretreated cells. At the same time point, untreated controls and
HMO-pretreated samples displayed vacuolar escape and cytoplasmic L. monocytogenes (Figure 2D–F).
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The effects of prebiotic blocking at 1% concentration on the ability of a pathogen to associate 
with cultured intestinal epithelial cells following 60 min of infection. No prebiotic control was 
normalized to 100% and samples were scaled to the control. Assays were carried out in biological 
and technical replicates (n = 3). The mean and SEM of each bar was graphed using Prism5 (GraphPad 
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Figure 2. TEM time course of L. monocytogenes infection. An infection time course of L. monocytogenes
with Caco-2 monolayers following 1% HMO and Biomos pretreatment was done. Cytosolic Listeria
are denoted by “c,” vacuole associated Listeria are denoted by “v.” Mitochondria are labeled as
“M”; microvilli are labeled as “MV,” actin filaments are labeled as “AF,” tight junctions are labeled
as “TJ.” Borders between two cells are indicated by the curved, dotted lines. (A–C) Intracellular
L. monocytogenes at 20 min post infection (p.i.). Black and white arrows indicate bacterial and vacuole
membrane. (D–F) L. monocytogenes at 40 min p.i. Inserts indicate lateral L. monocytogenes infection of
neighboring cells along with corresponding actin tails. (G–I) L. monocytogenes at 60 min p.i. Inserts
indicate differential infection stages between oligosaccharide pretreatments. (J–L) L. monocytogenes at
120 min p.i. Differential host outcome between oligosaccharide pretreatments. Black arrows indicate
L. monocytogenes cell e brane ruffling during bacterial clearance by the host.
The effects of prebiotic blocking at 1% concentration on the ability of a pathogen to associate with
cultured intestinal epithelial cells following 60 min of infection. No prebiotic control was normalized
to 100% and samples were scaled to the control. Assays were carried out in biological and technical
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replicates (n = 3). The mean and SEM of each bar was graphed using Prism5 (GraphPad Software,
La Jolla, CA, USA). Statistical calculations were done using JMP (SAS Institute, Raleigh, NC, USA),
to calculate/determine the statistical significance between samples as indicated by horizontal bars.
* p ≤ 0.05; ** p ≤ 0.01.
Where initial infection dynamics of HMO pretreatment were similar to the control, as the infection
time progressed, infection dynamics of Biomos pretreatment resembled that of the untreated control
beginning at 60 min p.i. (Figure 2G–I) with host cell lysis occurring at 120 min p.i. (Figure 2J–K).
Bacterial clearance via lysosomes was observed in HMO pretreatment at this time point p.i. (Figure 2).
These observations are counter to the theory that prebiotics act as a blocking molecule.
Rather these results expand the possible mechanism of action to include host modification leading to
subsequent alteration of host responses to pathogen invasion. We hypothesized a prebiotic-dependent
differential host response to be responsible for the observed decrease in Listeria host association and
thereby, examined host gene expression changes in the context of oligosaccharide pretreatment to
elucidate the host mechanisms that are responsible for the observed Listeria infection dynamics.
2.3. Biomos Drives Differential Expression of L. monocytogenes Genes during Infection
Only one L. monocytogenes gene (lmo_0758) was significantly differentially regulated
(log2FC = 0.245, FDR < 0.1) during the HMO treatment. While this gene has not been characterized
in Listeria, it is homologous to a glyoxalase protein found in Enterococcus sp. (100% query coverage,
48% identity, E-value 6e-92) that catalyzes the first step of the methylglyoxalase pathway. This gene
is induced under conditions of stress including bile acid and nutrient imbalances [31]. The lack of
differential central metabolism expression suggests that L. monocytogenes did not widely interact with
HMO during the time and constraints of this experiment, counter to proposed models for bacterial
modulation for HMO.
In contrast, the presence of Biomos during L. monocytogenes infection resulted in repression of
239 bacterial genes (Supplementary Table S2) and surprisingly no induced genes were observed.
Of the genes with known function, gene ontology functional characterization revealed repression of
numerous catabolism, membrane transport, motility and stress response genes. Gene set enrichment
analysis (GSEA) identified numerous genes significantly (p < 0.05) repressed that are components
of metabolic pathways involved in redox control, amino acid metabolism and secondary metabolite
catabolism (Table 1). Of these pathways, vitamin B12 (adenosylcobalamin) metabolism was the
most completely reconstructed (cobD log2FC = −10.807, p = 0.000002, FDR = 0.00007; lmo1164
log2FC = −1.858, p = 0.0056, FDR = 0.023; lmo1181 log2FC = −1.403, p = 0.0129, FDR = 0.0412).
Interestingly, three glycosyl hydrolases known to digest mannose-containing glycans were significantly
repressed in the presence of Biomos (lmo0688 log2FC = −1.792, p = 0.0013, FDR = 0.0095; lmo0864
log2FC = −1.925, p = 0.0046, FDR = 0.0207; lmo2521 log2FC = −2.089, p = 0.0014, FDR = 0.0095)
(Supplementary Table S2). Genes that code for simple sugar PTS transport were repressed that
effectively eliminated transport and phosphorylation of glucose, mannose, cellobiose and fructose;
thereby blocking their entry into central metabolism (Supplementary Figure S1). Taken together,
the repression of catabolic pathways and mannose-targeted glycosyl hydrolases associated with sugar
metabolism suggest that not only does the presence of Biomos alter L. monocytogenes metabolism but it
also influences L. monocytogenes cell wall composition, which may explain alteration of the pathogen’s
host association capabilities. This observation has not previously been described and may explain why
Listeria association increased 150% in the presence of Biomos.
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Table 1. Gene set enrichment analysis of Biomos-induced differentially expressed L. monocytogenes
genes at 60 min p.i. (Significance changes in enrichment were calculated using a two-tailed Fisher’s
exact test with p ≤ 0.05).
Function Pathways p-Value Genes Matched
Redox Cobalamin Biosynthesis 0.003 cobD, lmo1164, lmo1181
Cofactors, Prosthetic Groups,
Electron Carriers Biosynthesis 0.008
nadE, nadD, hemE, menE, hemA, cobD,
serC, panB, thyA, lmo2749, lmo2101,
lmo0938, lmo1930, lmo1164, lmo1181
Vitamins Biosynthesis 0.012 cobD, serC, panB, thyA, lmo2749,lmo2101, lmo1164, lmo1181
Adenosylcobalamin Biosynthesis 0.008 lmo1164, lmo1181
Adenosylcobalamin salvage from cobalamin 0.008
Biotin-carboxyl carrier protein assembly 0.022 accD, lmo1357
Vitamin B6 Biosynthesis 0.022 serC, lmo2101
Amino acid
metabolism Amino Acids Degradation 0.006
gltD, aspB, lmo2836, lmo2363, lmo0383,
lmo1182, lmo2101, lmo2749, lmo1915
Proteinogenic Amino Acids Degradation 0.006
L-aspartate Degradation 0.022 aspB, lmo1915
Aspartate degradation II 0.022
Aspartate superpathway 0.047 nadE, nadD, aspB, lmo1436, lmo1437
Pyrimidine deoxyribonucleosides salvage 0.022 thyA, lmo1463
Pyrimidine deoxyribonucleotides de novo
biosynthesis II 0.042 thyA, lmo0279
L-threonine Biosynthesis 0.039 aspB, lmo1436, lmo1437
Threonine biosynthesis 0.039
Energy
metabolism Degradation/Utilization/Assimilation 0.026
gltD, aspB, lmo0347, lmo2696, lmo1057,
lmo2648, lmo2836, lmo1463, lmo0877,
lmo1182, lmo0383, lmo2101, lmo2749,
lmo0372, lmo0917, lmo2771, lmo2840,
lmo1915, lmo2362, lmo2095, lmo2835
Secondary
metabolite
degradation
Taxiphyllin bioactivation 0.028 lmo0372, lmo0917, lmo2771
Nitrogen Containing Glucosides Degradation 0.028
Cyanogenic Glucosides Degradation 0.028
Nitrogen Containing Secondary
Compounds Degradation 0.039
3. Differential Gene Set Enrichment of Host Cell Signaling Pathways
In consideration of the differential localization of Listeria and vacuolar escape time between the
prebiotic treatments, we hypothesized that prebiotics independently modify the host cell to induce
novel signaling pathways that are protective against infection. This experiment resulted in 7752
and 316 significantly (false discovery rate (FDR) < 0.05) differentially expressed genes with Biomos
and HMO pretreatment in the colonic cell line, respectively. These genes represented canonical
signaling pathways involved with pathogen internalization, regulation of inflammation and cell
death. GSEA of host expression revealed a greater number of enriched genes in all pathways when
pretreated with Biomos as compared to HMO pretreatment with subsequent Listeria infection (Figure 3).
These observations support the hypothesis that prebiotics activate intrinsic protective responses in
the colonic cell to modulate the progression of L. monocytogenes infection. To verify this observation,
we examined infection before and after treatment of the host cell with prebiotics.
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Ratios were graphed Prism5 (GraphPad Software).
Examination of genes exhibiting the greatest differential expression revealed modulation of
numerous intracellular signaling events that spans from the cell membrane to the nucleus. The presence
of HMO during infection resulted in the significant (FDR < 0.05), differential repression of 11 genes,
all of which were small RNAs, with the largest repressed gene being SNORA53 with a log2 fold
change (FC) beyond −2 (Table 2). Conversely, the presence of Biomos during infection resulted in
significant (FDR < 0.05) differential expression of 3067 genes that included transcriptional regulators,
repression of cell cycle regulation, inflammation and ER stress genes as well as the induction of various
transmembrane receptors (Table 2).
We next examined the effect of L. monocytogenes infection in the presence of HMO and in
the presence of Biomos. Infection in the presence of HMO (HMO/+Lm) resulted in induction of
expression while infection in the presence of Biomos (Biomos/+Lm) led to repression of expression
(Table 3). The top four canonical pathways and functions that were differentially expressed included
ER stress, cell cycle regulation, transcription regulators and small RNAs. These results indicate that
prebiotic oligosaccharides were capable of influencing pathogen infectivity via the modulation of
host cell signaling pathways that would influence Listeria infection, which was observed in this
study (Figure 1). Furthermore, the differential activation or repression of host pathways were
oligosaccharide-dependent; suggesting that pretreatment with different oligosaccharides lead to
varying infection outcomes, as previously observed by modulation with different glycosylated
proteins [25–27,32].
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Table 2. Comparison of the differential gene expression with Listeria infection in Lm/+HMO and Lm/+Biomos treatments following 60 min of infection. Genes with
no significant differential expression are denoted by “ns” and their corresponding LogCPM, p-value and FDR values are denoted by “–”. Significance is defined as
FDR ≤ 0.05. Gene IDs are provided where possible. Ensembl IDs of each gene are listed.
Gene Function Gene Name Ensembl ID
Lm/+HMO Lm/+Biomos
Log2 FC LogCPM p-Value FDR Log2 FC LogCPM p-Value FDR
RNA-associated proteins, small
RNAs and pseudo-genes SNORA53/ACA53 ENSG00000212443 −3.347 1.672 3.25 × 10
−8 0.00021 ns – – –
RPPH1 ENSG00000277209 −1.420 4.499 2.5 × 10−5 0.04977 −3.598 4.651 2.5 × 10−11 2.8 × 10−9
RPPH1 ENSG00000259001 −1.417 4.502 2.5 × 10−5 0.04977 −3.584 4.653 1.9 × 10−11 2.3 × 10−9
AC010761.8 ENSG00000264577 −1.302 3.546 7.6 × 10−7 0.00374 −3.269 3.650 1.6 × 10−18 2.1 × 10−15
RN7SL5P ENSG00000278249 −1.553 1.421 2.5 × 10−6 0.00605 −1.797 1.729 2.3 × 10−5 2.0 × 10−4
SCARNA2 ENSG00000270066 −1.553 1.421 2.5 × 10−6 0.00605 −1.797 1.729 2.3 × 10−5 2.0 × 10−4
RN7SL5P ENSG00000265735 −1.243 2.999 1.5 × 10−6 0.00503 −1.658 3.278 3.0 × 10−5 2.4 × 10−4
SnoU2_19 ENSG00000275146 −1.138 1.452 1.2 × 10−6 0.00451 −1.340 1.747 1.1 × 10−3 4.3 × 10−3
RMRP ENSG00000277027 −1.316 3.178 2.6 × 10−8 0.00021 −1.182 3.614 1.1 × 10−2 2.9 × 10−2
RMRP ENSG00000269900 −1.315 3.178 2.8 × 10−8 0.00021 −1.182 3.614 1.1 × 10−2 2.9 × 10−2
AC084809.2 ENSG00000226377 ns – – – −3.743 2.709 5.4 × 10−20 9.3 × 10−17
RPL23A ENSG00000198242 ns – – – −3.530 6.238 3.2 × 10−25 1.4 × 10−21
RP11-3P17.5 ENSG00000269888 ns – – – −3.511 1.359 3.6 × 10−21 8.9 × 10−18
RPL23AP42 ENSG00000234851 ns – – – −3.511 1.359 3.6 × 10−21 8.9 × 10−18
RN7SL2 ENSG00000274012 ns – – – −3.330 7.607 5.1 × 10−11 4.9 × 10−9
AL627171.2 ENSG00000282885 ns – – – −3.317 7.609 3.2 × 10−11 3.4 × 10−9
AC010761.1 ENSG00000264577 ns – – – −3.269 3.650 1.6 × 10−18 2.1 × 10−15
RN7SL255P ENSG00000239808 ns – – – −2.975 0.630 5.3 × 10−8 1.4 × 10−6
AC121158.1 ENSG00000231335 ns – – – −2.707 2.933 4.6 × 10−13 9.6 × 10−11
MALAT1 ENSG00000278217 ns – – – −2.701 3.849 2.05 × 10−13 4.8 × 10−11
C11orf98 ENSG00000278615 ns – – – −2.683 1.110 5.45 × 10−17 4.5 × 10−14
CCDC74A ENSG00000163040 ns – – – 2.013 0.254 2.40 × 10−8 7.2 × 10−7
AC022966.2 ENSG00000267601 ns – – – 2.057 0.132 3.68 × 10−7 6.7 × 10−6
NRA5A1 ENSG00000136931 ns – – – 2.078 2.664 2.93 × 10−18 3.5 × 10−15
RP11-432M8.5 ENSG00000249329 ns – – – 2.079 0.360 3.51 × 10−11 3.6 × 10−9
AC113208.3 ENSG00000260660 ns – – – 2.111 0.784 5.66 × 10−9 2.2 × 10−9
AC017104.6 ENSG00000224376 ns – – – 2.122 −0.211 4.61 × 10−10 2.9 × 10−8
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Table 2. Cont.
Gene Function Gene Name Ensembl ID
Lm/+HMO Lm/+Biomos
Log2 FC LogCPM p-Value FDR Log2 FC LogCPM p-Value FDR
KRT16P2 ENSG00000227300 ns – – – 2.142 −0.021 2.7 × 10−8 7.8 × 10−7
PPP6R2P1 ENSG00000233442 ns – – – 2.148 −0.062 9.5 × 10−9 3.4 × 10−7
CA15P1 ENSG00000241527 ns – – – 2.172 −0.143 4.3 × 10−6 5.0 × 10−5
FAM90A22P ENSG00000215365 ns – – – 2.189 −0.027 1.8 × 10−9 8.7 × 10−8
BTBD17 ENSG00000204347 ns – – – 2.215 0.772 1.2 × 10−9 6.5 × 10−8
RP11-26H16.4 ENSG00000283234 ns – – – 2.309 0.035 1.6 × 10−11 2.0 × 10−9
RP11-331F4.5 ENSG00000280152 ns – – – 2.348 0.207 3.5 × 10−10 2.3 × 10−8
SLC25A34 ENSG00000162461 ns – – – 2.904 −0.043 4.9 × 10−12 7.5 × 10−10
Tran-scriptional regulators ZBED6 ENSG00000257315 ns – – – −2.625 2.892 5.7 × 10−15 2.6 × 10−12
ZNF703 ENSG00000183779 ns – – – 2.680 2.689 1.3 × 10−18 1.9 × 10−15
HO × D10 ENSG00000128710 ns – – – 2.041 0.792 8.3 × 10−11 7.4 × 10−9
Cell cycle NAMPTP1 ENSG00000229644 ns – – – −3.272 0.963 1.5 × 10−26 8.6 × 10−23
GADD45A ENSG00000116717 ns – – – −2.684 2.171 3.0 × 10−16 2.0 × 10−13
Inflammation TNFAIP3 ENSG00000118503 ns – – – −3.054 4.040 7.2 × 10−21 1.6 × 10−17
JUN ENSG00000177606 ns – – – −3.436 3.904 3.9 × 10−33 4.4 × 10−29
FOS ENSG00000170345 ns – – – −2.871 3.398 9.4 × 10−16 5.4 × 10−13
Endoplasmic reticulum stress HSPA1A ENSG00000204389 ns – – – −2.883 3.702 1.8 × 10−34 4.2 × 10−30
HSPA1B ENSG00000204388 ns – – – −2.749 3.423 6.5 × 10−30 4.9 × 10−26
PSMD10 ENSG00000101843 ns – – – −2.749 1.833 1.0 × 10−22 3.9 × 10−19
Cell structure SPTBN5 ENSG00000137877 ns – – – 2.017 3.286 3.7 × 10−16 2.4 × 10−13
MYL3 ENSG00000160808 ns – – – 2.125 2.038 4.5 × 10−15 2.1 × 10−12
Receptors GRASP ENSG00000161835 ns – – – 2.068 1.589 1.1 × 10−13 2.8 × 10−11
TMEM82 ENSG00000162460 ns – – – 2.091 0.168 1.6 × 10−8 5.1 × 10−7
CHRND ENSG00000135902 ns – – – 2.130 0.405 1.9 × 10−10 1.4 × 10−8
UCHL1 ENSG00000154277 ns – – – 2.165 3.558 7.8 × 10−19 1.2 × 10−15
GPR142 ENSG00000257008 ns – – – 2.211 0.751 2.1 × 10−11 2.4 × 10−9
GFRA4 ENSG00000125861 ns – – – 2.218 0.069 5.2 × 10−9 2.1 × 10−7
CABP7 ENSG00000100314 ns – – – 2.285 1.519 3.1 × 10−10 2.1 × 10−8
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Table 3. Comparative transcriptomics of Biomos differentially expressed genes in HMO/+Lm and Biomos/+Lm following 60 min of infection. Genes with no
significant differential expression are denoted by “ns” and their corresponding LogCPM, p-value and FDR values are denoted by “–”. Significance is defined as
FDR ≤ 0.05. Gene IDs are provided where possible. Ensembl IDs of each gene are listed.
Gene Function Gene Name Ensembl ID
HMO/+Lm Biomos/+Lm
Log2 FC LogCPM p-Value FDR Log2 FC LogCPM p-Value FDR
ER stress and
protein folding YOD1 ENSG00000180667 1.927 1.527 1.3 × 10
−5 9.1 × 10−3 −2.505 1.413 1.1 × 10−14 1.1 × 10−11
HSPA1B ENSG00000204388 3.146 3.801 1.8 × 10−9 1.1 × 10−5 −3.009 3.528 6.2 × 10−30 3.5 × 10−26
HSPA1A ENSG00000204389 3.228 4.070 1.1 × 10−10 1.2 × 10−6 −3.145 3.813 1.1 × 10−32 1.6 × 10−28
HSPH1 ENSG00000120694 2.062 4.095 3.3 × 10−5 1.5 × 10−2 −1.579 3.787 4.6 × 10−12 1.6 × 10−9
INSIG1 ENSG00000186480 2.432 4.979 2.6 × 10−6 4.3 × 10−3 −1.480 4.788 5.7 × 10−8 3.2 × 10−6
PSMD10 ENSG00000101843 1.912 1.654 2.6 × 10−6 1.3 × 10−2 −2.668 1.579 2.6 × 10−12 1.0 × 10−9
Inflammation TNFAIP3 ENSG00000118503 ns – – – −2.897 3.777 1.4 × 10−32 1.6 × 10−28
NFKB1A ENSG00000100906 ns – – – −2.591 2.723 4.0 × 10−22 1.5 × 10−18
JUN ENSG00000177606 ns – – – −3.407 3.751 1.7 × 10−31 1.3 × 10−27
Cell cycle GADD45A ENSG00000116717 2.083 2.346 4.0 × 10−5 1.7 × 10−2 −2.878 2.215 6.8 × 10−25 3.1 × 10−21
TXNIP ENSG00000265972 2.645 5.494 5.5 × 10−5 1.8 × 10−2 −2.066 5.187 4.4 × 10−12 1.5 × 10−9
NAMPT ENSG00000105835 2.325 5.180 2.3 × 10−5 1.2 × 10−2 −2.363 5.024 1.3 × 10−12 5.8 × 10−10
NAMPTP1 ENSG00000229644 2.563 0.994 6.5 × 10−6 7.4 × 10−3 −3.402 0.934 5.5 × 10−22 1.8 × 10−18
Miscellaneous functions TIPARP ENSG00000163659 2.557 5.719 3.4 × 10−6 5.3 × 10−3 −1.055 5.777 1.2 × 10−5 1.9 × 10−4
CD164 ENSG00000135535 2.280 5.575 4.8 × 10−5 1.7 × 10−2 −1.970 5.610 2.7 × 10−10 4.5 × 10−8
GGCT ENSG00000006625 2.154 1.467 1.1 × 10−5 9.1 × 10−3 −2.651 1.532 2.2 × 10−10 3.9 × 10−8
Transcriptional regulator FOS ENSG00000170345 2.520 3.030 4.6 × 10−8 1.5 × 10−4 −2.468 2.890 2.4 × 10−13 1.4 × 10−10
ZNF703 ENSG00000183779 −2.001 2.473 2.9 × 10−4 3.8 × 10−2 2.141 2.674 4.6 × 10−16 5.7 × 10−13
ZBED6 ENSG00000257315 2.622 2.535 5.6 × 10−6 7.4 × 10−3 −2.181 2.362 7.9 × 10−11 1.7 × 10−8
KLF6 ENSG00000067082 2.010 5.008 1.6 × 10−4 3.0 × 10−2 −1.625 4.845 8.8 × 10−8 4.5 × 10−6
RNA-associated proteins,
small RNAs
and pseudogenes
HNRNPA1 ENSG00000135486 2.397 5.602 5.1 × 10−5 1.7 × 10−2 −2.433 5.567 8.5 × 10−17 1.2 × 10−13
RPL23A ENSG00000198242 2.198 5.435 2.3 × 10−8 8.7 × 10−5 −3.133 5.742 4.1 × 10−21 1.2 × 10−17
RPPH1 ENSG00000277209 1.596 3.351 1.9 × 10−6 3.6 × 10−3 −2.905 3.885 1.7 × 10−8 1.3 × 10−6
MRPL36 ENSG00000171421 2.083 1.352 1.4 × 10−9 1.1 × 10−5 −2.502 1.916 4.0 × 10−15 4.5 × 10−12
RN7SL255P ENSG00000239808 4.349 0.639 3.2 × 10−9 1.5 × 10−5 −2.712 0.329 2.2 × 10−13 1.4 × 10−10
KRT17P4 ENSG00000205312 −1.575 0.132 4.3 × 10−4 4.3 × 10−2 2.258 0.067 8.1 × 10−11 1.8 × 10−8
RPL23AP42 ENSG00000234851 1.831 0.804 1.3 × 10−5 9.1 × 10−3 −3.126 0.824 7.1 × 10−14 5.2 × 10−11
AC084809.2 ENSG00000226377 4.358 2.636 2.3 × 10−15 5.4 × 10−11 −3.823 2.643 5.6 × 10−18 1.1 × 10−14
AC107072.2 ENSG00000231335 2.105 2.386 4.4 × 10−5 1.7 × 10−2 −1.749 1.998 4.6 × 10−11 1.2 × 10−8
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Table 3. Cont.
Gene Function Gene Name Ensembl ID
HMO/+Lm Biomos/+Lm
Log2 FC LogCPM p-Value FDR Log2 FC LogCPM p-Value FDR
CTD-202417.13 ENSG00000246422 2.286 1.332 6.4 × 10−6 7.4 × 10−3 −1.227 1.357 1.1 × 10−6 3.1 × 10−5
MACC1-AS1 ENSG00000228598 2.466 1.806 6.7 × 10−7 1.8 × 10−3 −2.101 1.410 5.2 × 10−13 2.8 × 10−10
CTD-3014M21.1 ENSG00000279602 2.594 2.937 9.4 × 10−6 8.6 × 10−3 −1.983 2.744 1.7 × 10−11 4.8 × 10−9
RPPH1 ENSG00000259001 1.590 3.357 2.0 × 10−6 3.6 × 10−3 −2.893 3.890 1.4 × 10−8 1.1 × 10−6
RP11-3P17.5 ENSG00000269888 1.823 0.806 1.0 × 10−5 8.9 × 10−3 −3.126 0.824 7.1 × 10−14 5.2 × 10−11
RPS13 ENSG00000110700 1.784 5.309 4.2 × 10−5 1.7 × 10−2 −2.705 5.665 1.5 × 10−13 10.0 × 10−11
AC010761.8 ENSG00000264577 1.296 2.570 3.2 × 10−4 3.9 × 10−2 −2.607 2.914 6.5 × 10−13 3.4 × 10−10
RN7SL2 ENSG00000274012 ns – – – −2.892 7.104 3.8 × 10−8 2.4 × 10−6
RP11-596C23.6 ENSG00000282885 ns – – – −2.880 7.107 2.6 × 10−8 1.8 × 10−6
DNASE1L3 ENSG00000283148 ns – – – 2.226 −0.175 6.2 × 10−11 1.5 × 10−8
RP11-321E2.8-001 ENSG00000250055 ns – – – 2.400 −0.013 4.9 × 10−13 2.7 × 10−10
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4. Prebiotic-Dependent Differential Expression of Host Cell Stress Signaling during Infection
HMO pretreatment prior to L. monocytogenes infection (HMO/+Lm) activated host transmembrane
receptors while Biomos pretreatment (Biomos/+Lm) repressed these same receptors (Supplementary
Table S3). Twenty-five transcription factors were significantly (p≤ 0.0025, FDR ≤ 0.0459) differentially
expressed in both Biomos/+Lm and HMO/+Lm. Ten of these transcription factors, including FOS,
JUNB and PSMD10, were induced in HMO/+Lm and involved in the host cell cycle regulation and stress
response. These same genes were repressed in the Biomos/+Lm treatment (Supplementary Table S3).
Infection with HMO pretreatment resulted in the differential expression of 316 host genes. Only 22
of these genes were unique to this treatment when compared to infection with Biomos pretreatment.
Seven out of 22 of these genes were involved in membrane structure and intracellular signaling. Members
of the phospholipid signaling pathway involved in host defense against pathogens, LCAT (log2FC =−1.17,
p = 0.00043, FDR = 0.043) and PLA2G3 (log2FC = −1.58, p = 0.00004, FDR = 0.0171) were significantly
repressed. Interestingly, an anti-apoptotic factor-encoding gene, MTRNR2L8, was significantly induced
(log2FC = 1.41, p = 0.00003, FDR = 0.0153) (Supplementary Table S4). Twenty-four cytokines were uniquely
expressed during infection with Biomos pretreatment with all but three cytokines being differentially
induced (Supplementary Table S4). Taken together, the induction of an anti-apoptotic factor with HMO
versus induction of a cytokine-mediated inflammatory response with Biomos, suggests a prebiotic-driven
alteration of differential host cell stress and death signaling pathways during L. monocytogenes infection
rather than a blocking mechanism to alter Listeria association. Additionally, these observations support the
observed lack of host cell death in this study during infection with HMO treatment in contrast to the host
lysis and increase of Listeria invasion with Biomos treatment. The observed HMO-induced host survival
coupled with the 50% decrease in L. monocytogenes host association suggests that HMO pretreatment
activates host mechanisms of intracellular pathogen clearance, preventing host death during the time of
this experiment.
5. Biomos Expedites L. monocytogenes Vacuolar Escape
Upon host entry, L. monocytogenes is contained within a vacuole that is subsequently lysed by
the L. monocytogenes virulence effector protein, LLO, to allow vacuole escape and cellular spread
during infection progress. Vacuole escape and subsequent access to the cytosol allows L. monocytogenes
activation of cytosolic host receptors, such as STING, a host receptor for c-di-AMP and an indicator
of L. monocytogenes vacuole escape. Due to the observation of STING induction in the presence of
Biomos, we examined host and bacterial expression of c-di-AMP synthesis and transporter genes
to ascertain the source of STING activation. No significant differential expression was observed
with host c-di-AMP synthase (MB21D1) with either prebiotic treatment, indicating that there was no
prebiotic-driven differential c-di-AMP synthesis by the host. In contrast, L. monocytogenes c-di-AMP
synthase (dacA, lmo2120) was significantly repressed in the presence of Biomos (log2FC = −1.75).
Interestingly, bacterial c-di-AMP degradation (pdeA, lmo0052) and transport (marR, lmo1618)
were also repressed in the presence of Biomos (log2FC = −3.74, log2FC = −10.01, respectively)
(Supplementary Table S2), which are consistent with the increase in infection. No significant differential
expression was observed in these genes with HMO pretreatment. These results demonstrate that
Biomos pretreatment decreased L. monocytogenes degradation of c-di-AMP, as well as increased
transport of bacterial c-di-AMP into the host cytosol. Taken together, these results indicate that
L. monocytogenes degradation of c-di-AMP was repressed while c-di-AMP transport out of the cell
was induced with Biomos pretreatment, indicating that the observed STING induction (Figure 4A)
was due to the presence of cytosolic L. monocytogenes. To ascertain the consequences of differential
L. monocytogenes subcellular localization on the host, we next evaluated the differential expression of
host signaling pathways involved in responses to L. monocytogenes invasion.
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oligosaccharides. Differential expression (log2FC) of individual genes visualized by heat map.
Bacterial differential expression ranges from −10 < log2FC < 10; host differential expression ranges
from −4 < log2FC < 4. HMO/+Lm is indicated as “H”; Biomos/+Lm is indicated as “B.” HMO is
indicated by squares, triangles and circles above the membrane; Biomos is indicated by the hexagons
above the membrane. (A) Differential subcellular localization is indicated by the intact double circle
(H, vacuole associated) versus the dotted line double circle (B, vacuolar escape). c-di-AMP synthesis,
transport and degradation genes are listed with arrow weights indicating host vs. bacterial contribution
to cytosolic c-di-AMP. (B) Differential expression of signaling pathways with prebiotic treatment.
(C) Differential expression of transcription factors and pseudogenes with prebiotic treatment.
6. HMO Pretreatment Potentiates Host Cellular Intrinsic Protective Response during
L. monocytogenes Infection
Given the observed prebiotic-dependent regulation of host signaling pathways (Tables 2 and 3)
coupled with differential L. monocytogenes association and subcellular localization (Figure 2),
we anticipated drastically different host stress responses to pathogen invasion with different
prebiotic treatments. Despite the greater magnitude of host association with Biomos pretreatment,
L. monocytogenes infection with Biomos pretreatment repressed host protective responses of misfolded
protein accumulation with repression of heat shock proteins (HSPH1, HSPA1, HSPA) in the UPR
pathway and ER-associated INSIG1. In conjunction with repressed UPR expression, infection with
Biomos decreased expression of the ER stress pathway while no change was observed with HMO
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(Supplementary Figure S1). Infection with Biomos pretreatment also repressed expression of the eIF2
signaling pathway including PPP1CB and numerous phosphatases, as well as stress and inflammatory
response transcription factors including ATF3, FOS and JUN. These results are contradictory to the
induction of UPR and ER stress that is typically observed with L. monocytogenes infection.
Conversely, infection with HMO pretreatment led to induction of UPR and the eIF2 pathway
as well as induction of inflammation-associated transcription factors FOS, JUN, IRF5 and TGFB1.
Host autophagy, an endpoint to cellular stress and injury, was induced during infection with Biomos
pretreatment but repressed with HMO pretreatment (Figure 4B,C). Taken together, these results
demonstrate that contrary to the wide-spread belief that prebiotics block pathogens via physical
exclusion, addition of prebiotics prior to infection led to modulation of differential pathway activation
of many host signal transduction pathways in colonic cells that alter pathogen infection route and
duration. While HMO reduced the total Listeria association, both prebiotics led to cellular responses
to interrupt Listeria infection via different mechanisms. Infection in the presence of HMO induced
an intrinsic response in epithelial cells to enhance pathogen clearance, while infection in the presence
of Biomos potentiated autophagic host cell death.
7. Discussion
Successful application of prebiotics, particularly within susceptible populations, such as
neonates and immunocompromised individuals, is thought to alter the course of infection from
septicemia to mild gastroenteritis. This de-escalation of infection is thought to be accomplished
through prebiotic-driven functional enrichment for community members, such as bifidobacteria and
lactobacilli. These selected members are capable of metabolizing complex oligosaccharides beyond the
capabilities of enteric pathogens; thereby, giving probiotic bacteria a selective advantage to restrict
the microbiome community structure to exclude pathogens [17,33,34]. While prebiotic-beneficial
microbiota interactions in disease prevention are partially understood, the direct mechanisms of action
in prebiotic reduction of pathogens are yet to be described beyond immune-activating capabilities [35].
Inadequate explanations for various microbiome associations leave large gaps in strategic use of
oligosaccharides to direct the microbiome to specific endpoint to reduce infection and pathogen
carriage [25–27].
Prebiotic oligosaccharides are used in agriculture and in the human diet to improve colon health
and minimize gut-associated infectious disease. Some studies demonstrate HMO to modulate pathogen
association in vitro [16,36]. Despite these observations of pathogen reduction, the impact of prebiotic
oligosaccharides on host intracellular protective mechanisms of action, beyond short chain fatty
acid production, remains largely unstudied [37]. Cell membrane-associated glycans and protein
glycosylation patterns drive cell-to-cell and intracellular signaling in eukaryotic systems [38,39].
Given the structural similarities between prebiotic oligosaccharides and membrane-associated glycans,
we sought to elucidate the effect of dietary glycans on L. monocytogenes association with the colonic
epithelial barrier with the hypothesis that prebiotic oligosaccharides modulated L. monocytogenes host
association by changing the host membrane and signaling cascades. Mannanoligosaccharides are
used to reduce enteric pathogens and shedding in livestock; although, the effect on L. monocytogenes
infection remains to be explored [16,40].
8. Effect of Prebiotics on L. monocytogenes Host Association and Gene Expression
Consistent with observations from previous studies using various enteric pathogens,
HMO treatment of intestinal epithelial monolayers prior to infection led to a 50% decrease the number
of host-associated L. monocytogenes (Figure 1) [16]. Interestingly, pretreating Caco-2 monolayers
with mannan- and fructo-oligosaccharides increased L. monocytogenes infectivity. Studies on the
efficacy of mannanoligosaccharides to lower enteric pathogens reported reductions in Clostridium and
Escherichia coli; however, in this study we observed a 150% increase in L. monocytogenes infection in the
presence of Biomos (Figure 1). Our observations agreed with Park et al. [41], who reported increased
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Salmonella internalization with high mannose glycans. Alterations to the glycosylation profile of host
glycoproteins such as the human milk lactoferrin are also associated with modulation of pathogen
association with colonic epithelial cells and reduced pathogen shedding [26]. Findings from this
study suggest that L. monocytogenes recognizes but does not degrade the terminal mannose units of
Biomos as a host receptor. Instead of bacterial clearance, this recognition leads to increased pathogen
internalization (Figure 1). Due to the differential host association observed with prebiotic treatment,
we sought to elucidate L. monocytogenes responses to oligosaccharide presence.
The presence of HMO exhibited no transcriptional effect on intracellular L. monocytogenes,
suggesting that the reduced infective phenotype with HMO pretreatment was a result of HMO
acting on host cell receptors and signaling cascades (Supplementary Table S4). In contrast,
the presence of Biomos resulted in a repression of many L. monocytogenes metabolic pathways, enzymes,
replication and cell wall associated genes (Supplementary Table S2)—namely redox, amino acid
metabolism and energy metabolism (Table 1). The observed catabolic repression could be attributed
to the abundance of mannose-containing glycans in the infection milieu: after 60 min of exposure
to high nutrient conditions, the microbe has saturated the input end of carbohydrate metabolic
pathways, alleviating the need for continued reaction progression [42]. While one might expect to
see an induction of glycosyl hydrolases, the observed expression repression in this study may be
a result of the abundance of extracellular mannosyl-oligosaccharides due to Biomos pretreatment,
thereby repressing expression of many of these enzymes. Lipoteichoic acid composition has
been shown to be necessary for Listeria host association and infection [43]. Interestingly, lmo2521
(N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase) encodes
a glycosyl hydrolase and plays a role in L. monocytogenes teichoic acid biosynthesis. While little is
known about Listeria glycosyl hydrolases, their involvement in shaping teichoic acid composition raises
interesting questions about the capacity for prebiotic oligosaccharides to initiate cell wall restructuring
in bacteria and their subsequent capacity to interact with the host during infection but suggests that
this may play a role in colonic cell association.
Prebiotic oligosaccharides can be metabolized by the intestinal microbiota into molecules, such as
short chain fatty acids, that subsequently modulate host cellular responses [37]. The Biomos-induced
L. monocytogenes metabolic repression observed in this study suggests that in the presence of
mannanosyl-oligosaccharides, L. monocytogenes metabolism is dampened, leading to decreased Listeria
metabolism and increased host contact with intact prebiotics.
Vitamin B12 (adenosylcobalamin) metabolic genes are induced during L. monocytogenes
intracellular replication and anaerobic respiration. L. monocytogenes synthesis of vitamin B12 is thought
to generate a pathogenic niche during infection by facilitating growth on ethanolamine as a carbon
or nitrogen source to aid in progression of the infection [44]. Our findings of repressed vitamin B12
synthesis suggest that Biomos pretreatment either negatively impacts L. monocytogenes replication or
that L. monocytogenes is encountering a less anaerobic environment, relieving the need for vitamin B12 to
undergo anaerobic respiration with ethanolamine [44]. This is consistent with the observed repression
of genes associated with flagellar production, indicating an alternative association mechanism is at
work with Biomos and Listeria. Given the observation of both bacterial replication at T60 with Biomos
treatment and host autophagy (Figure 2K), it is likely that the repression of vitamin B12 metabolic
genes was due to an aerobic environment brought about by host cell death.
9. Prebiotic-Driven L. monocytogenes Vacuolar Escape
Upon host internalization, L. monocytogenes initially resides in a vacuole prior to accessing
the cytosol. Vacuolar escape and subsequent cytosolic access is enabled by expression of the
bacterial virulence factor, listeriolysin O [45]. Different phases of L. monocytogenes infection are
benchmarked by induction of specific host genes: heat shock protein 70 (HSP70) as marker for
early infection, vacuole-associated L. monocytogenes and stimulator of interferon genes (STING)
as a marker for cytosolic L. monocytogenes [46,47]. Hsp70 plays a dual role during infection:
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stabilization of the phagosome to prevent vacuolar escape and as a chaperone for misfolded
proteins [48]. Although HSP70 induction is typically associated with early (15 min p.i.) L. monocytogenes
infection, we found HSP70 to be induced (Figure 4A) with cytosolic L. monocytogenes by 60 min
p.i. (Figure 2I), suggesting a protective role for Hsp70 against L. monocytogenes-induced misfolded
proteins [48]. Upon vacuolar escape, cytosolic L. monocytogenes secretes c-di-AMP, activating the
host c-di-AMP binding protein STING [49]. Differential repression of L. monocytogenes c-di-AMP
degradation (lmo0052) and a c-di-AMP transporter repressor (lmo1618) coupled with repression
of host cGAMP synthase (MB21D1) point to L. monocytogenes c-di-AMP as the source of STING
induction (Figure 4A) [50]. Furthermore, HSP70 induction by HMO treatment opposed to STING
induction with Biomos suggests prebiotic-dependent differential subcellular localization of intracellular
L. monocytogenes (Figure 2A–C,M, Figures 4A and 5). Time course TEM imaging of L. monocytogenes
infection revealed enhanced L. monocytogenes vacuolar escape with Biomos pretreatment prior to
20 min p.i. while L. monocytogenes in control and HMO-treated samples remained vacuole-associated
(Figure 2A–C). Although eventual vacuolar escape and lateral infection is observed in HMO treated
cells (Figure 2C,F,I), bacterial clearance by the host at 60 min p.i. is unique to HMO pre-treatment
(Figure 2M). In contrast, infected host cells in both control and Biomos-treated samples were observed
to undergo cell death (Figure 2J,K).
10. Host Cell Intrinsic Responses against L. monocytogenes Invasion
Early vacuolar escape into the cytosol provides an opportunity for Listeria to damage the colonic
cell using various methods that broadly disrupt signal transduction that ultimately end in cell
death. Gene expression modification of oligosaccharide-treated Caco-2 monolayers during infection
(HMO/+Lm and Biomos/+Lm) revealed a global reduction in pathogen-induced and host stress
signaling pathway enrichment with HMO, showing that infection in the presence of Biomos modulated
40-fold more genes than did infection in the presence of HMO (Figure 3). Despite the canonical
pathway enrichment disparity between prebiotic treatments, analysis of differentially expressed genes
shared between both treatments revealed changes in key genes involved in the regulation of cell
cycle, inflammation, ER stress and cell structure (Table 2). Additionally, expression profiles were
inversely related between HMO/+Lm and Biomos/+Lm—genes induced with one treatment were
repressed with the other treatment. As expected, the addition of extrinsic glycans in the form of
prebiotic oligosaccharides modulated host membrane receptors during L. monocytogenes infection
(Supplementary Table S3). Our observation of differentially expressed inflammatory mediators
and differentiation-related transcriptional regulators suggests direct modulation of intracellular
transcriptional responses within the host (Supplementary Table S3). In addition to previously reported
effects of prebiotic oligosaccharides on immunomodulation, our results indicate changes to host
differentiation patterns, which have only been reported in mesenchymal stem cells infected with
bacteria [51]. These unexpected results indicate that prebiotics are capable of directly reshaping the
transcriptomic landscape of epithelial cells to prime an antimicrobial response in non-phagocytic
host cells.
Biomos pretreatment directly and negatively regulated inflammation and ER stress but induced
expression of cell surface receptors and cell structure components (Table 2). Although HMO itself
did not result in any observable changes in expression of signaling pathways at 60 min p.i. (Table 2),
the identification of differentially regulated small RNAs suggests ability for HMO to prime cellular
immunity, allowing for a more rapid response if infection should occur [52]. This HMO-driven
differential regulation of transcription factors has been previously observed in cases of allergic and
infection-driven immune activation [53,54]. Unexpectedly, numerous small RNAs were found to
be significantly and highly modulated with prebiotic treatment. This observation is in line with
findings from previous transcriptome profiling studies [55–57]. Additionally, our findings suggest that
prebiotic oligosaccharides are not only able to modulate the host cell surface but they are capable of
influencing host post-transcriptional modification systems. Small nucleolar RNA (SNORA53) was
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the only RNA-coding gene to be differentially expressed in Lm/+HMO but not in Lm/+Biomos
(Table 2). Although the target sequences for SNORA53 have yet to be mapped, this finding suggests
that the presence of HMO during L. monocytogenes infection initiates post-transcriptional modification
of a different subset of mRNA compared to Biomos [58,59]. Broadly, these results suggest that
transcriptome modulation pattern is specific to different species of prebiotic oligosaccharides. The role
in the infection biology remains unclear, in spite of the large regulatory changes with HMO.
Lecithin-cholesterol acyltransferase (LCAT) and phospholipase A2 group III (PLA2G3) were
two genes uniquely regulated by HMO/+Lm that were not differentially regulated in the Biomos/+Lm
treatment (Supplementary Table S4). LCAT and PLA2G3 are both involved in the phospholipid
signaling pathway. Changes in LCAT abundance can result in modulation of host membrane fluidity
and cholesterol concentration while PLA2G3 is a member of secreted phospholipase A2 family with
protective activity against microbial pathogens [60–62]. The finding of these two uniquely differentially
expressed genes in HMO/+Lm provides additional evidence of HMO-induced alterations to the colonic
cell surface and subsequent signaling cascades. These alterations contribute to a host response of active
reduction L. monocytogenes association rather than a passive response by the prebiotic in blocking
pathogen adhesion.
STING, a host marker for cytosolic c-di-AMP, was induced during L. monocytogenes infection with
Biomos pretreatment. We determined L. monocytogenes to be the source of c-di-AMP during Biomos
treatment due to the observed repression of Listeria c-di-AMP degradation and transport repressor,
with a concurrent lack of differential host c-di-AMP synthesis (Figure 4). Despite the observed STING
induction, no significant differential expression of the genes involved in a subsequent interferon
regulatory factor 3 (IRF3)-dependent type 1 interferon (IFN) response were observed. This is likely
due to repression of the STING binding partner, tank binding kinase 1 (TBK1) (Figures 4B and 5),
whose induction is needed to activate IRF3 [63].
The activation of the autophagy related 9b (ATG9b) gene, an apoptosis enucleation factor and
a negative regulator of TBK1, supports the observation of TBK1 repression and corroborates the
observed induction of the apoptosis signaling pathway with Biomos pretreatment [64]. These results
suggest that while L. monocytogenes host invasion with Biomos pretreatment follows the canonical
steps of initial host entry, the presence of Biomos during infection represses the subsequent host cell
intrinsic protective response [47,49,65]. This repression ultimately results in increased bacterial burden
and increased host death.
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are depicted by dark grey ovals (Listeria). Enhanced vacuolar escape with Biomos pretreatment is
indicated by dotted grey line.
L. monocytogenes host invasion modulates numerous signal transduction pathways including
eukaryotic initiation factor 2 (eIF2) signaling and the unfolded protein response (UPR) [9,10].
eIF2 signaling serves to modulate mRNA translation in response to stress while UPR acts to contain
and control damages made by stress-induced protein misfolding. As a part of eIF2 signaling,
induction of activating transcription factor 3 (ATF3) during intracellular bacterial infection enhances
pathogen clearing [66]. Consistent with previous findings, induction of the eIF2 pathway and ATF3
expression with HMO pretreatment was correlated with decreased intracellular L. monocytogenes
burden (Figures 1 and 4B,C) as well as with enhanced pathogen clearing and decreased host cell death
at 120 min post infection with HMO pretreatment (Figures 2 and 5) [9,66]. In contrast, repression of the
UPR with Biomos pretreatment likely allowed for a buildup of infection-induced misfolded cytosolic
proteins [10]. This occurrence contributed to the induction of apoptosis signaling and subsequent
increased host cell death (Figures 3 and 4B), allowing for pathogen dissemination to begin another
round of infection into neighboring host cells [65].
11. Materials and Methods
11.1. Oligosaccharides
Raftiline was obtained from Orafti (Lot# HPBNL23JP3, Malvern, PA, USA). Bio-BIOMOS and
Actigen were supplied by Alltech Inc. (Nicholasville, KY, USA). HMO was isolated and gifted to the
Weimer lab by Dr. Daniela Barile (UC Davis, CA, USA) [67]. Plant and yeast-derived oligosaccharides
were in powder form and stored dry at room temperature. HMO was stored at −20 ◦C until use.
All oligosaccharides were resuspended in high glucose DMEM (HyClone Laboratories, Logan, UT,
USA) at a 1% working concentration.
11.2. Bacterial Strains and Growth Conditions
L. monocytogenes strain EGD-e was obtained from ATCC (BAA-679). Stock cultures were stored in
nonfat dry milk with glycerol at −80 ◦C. L. monocytogenes cultures were grown in brain heart infusion
(BHI) broth. Cultures were incubated in BHI broth for 4 to 6 h at 37 ◦C to reach exponential phase or
for 14 h to reach early stationary phase. Second transfers were carried out by transferring 1% of the
exponential phase cultures to fresh BHI broth and incubated at 37 ◦C for 14 h.
11.3. Human Cell Line and Growth Conditions
Human colonic carcinoma (Caco-2) cell lines were obtained from ATCC (HTB-37). Caco-2 stocks
were stored in DMEM with 10% DMSO in liquid nitrogen. Thawed Caco-2 cells were grown in DMEM
with 10 mM MOPS (Sigma, St. Louis, MO, USA), 10 mM TES (Sigma, St. Louis, MO, USA), 15 mM
HEPES (Sigma, St. Louis, MO, USA), 2 mM NaH2PO4 (Sigma, St. Louis, MO, USA), 20% fetal bovine
serum (HyClone Laboratories), 1% glutamax (Thermo Scientific, Rockford, IL, USA), 1% PenStrep
(Thermo Scientific, Rockford, IL, USA) and 1% non-essential amino acids (Thermo Scientific, Rockford,
IL, USA). Cells were grown to confluency and differentiated for 12 to 15 days before use in gentamicin
protection assays. Caco-2 cells were seeded into 96-well plates 14 days prior at 10,000 cells/cm2.
Culture medium was renewed every three days.
11.4. In Vitro Colonic Cell Infection Assays
Colonic cell (Caco-2) infection assays were performed as previously described [68] and modified by
Shah et al. [69,70]. Briefly, differentiated Caco-2 cells were pre-treated with 1% oligosaccharide suspended
in serum-free DMEM. Following a 15-min incubation in the presence of oligosaccharides, Caco-2 cells
were exposed to early stationary phase L. monocytogenes (n = 3; multiplicity of infection = 1000) for 60 min.
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Cells were washed with PBS buffer (pH = 7.2) and lysed with 50 ml Warnex buffer (AES Chemunex
Canada, Inc., Montreal, QC, Canada) following manufacturer’s directions.
Warnex lysis was deactivated by incubation at 95 ◦C for 15 min. Samples were diluted 1:10 in
nuclease-free water and stored at −20 ◦C pending qPCR quantification as described by Arabyan et al.
using forward (F) and reverse (R) PCR primers (F) 5′-CTCAAATACGAATGCTAACCAAGGT-3′ and
(R) 5′-TTTGAGCTTCAGCAATAATAGCACTT-3′ [22]. Quantification was done using qPCR with
results reported as number of L. monocytogenes colony forming units (cfu)/Caco-2 cell. All samples
were assayed in biological and technical triplicate and graphed using the statistical software,
GraphPad InStat 3 (GraphPad Software, Inc., La Jolla, CA, USA) and ANOVA with Tukey’s test
using JMP version 10 (SAS Institute, Triangle Park, NC, USA). Data are displayed as the mean ± SEM
with three biological replicates. p < 0.05 was considered to be statistically significant.
11.5. RNA Extraction
Differential host lysis was done with infected samples by passaging cells through a 22 gauge
needle [71]. Bacterial cells were enzymatically lysed following the protocol used by the 100 K Pathogen
Genome PROJECT for bacterial lysis [72]. Samples were pelleted via centrifugation and suspended in
Trizol LS. RNA was extracted from TRIzol LS (Ambion #10296) following manufacturer instructions.
RNA purity (A260/230 and A260/280 ratios ≥ 1.8, ≤ 2.0) and integrity were confirmed with Nanodrop
(Nanodrop Technologies, Wilmington, DE, USA) and BioAnalyzer RNA kit (Agilent Technologies Inc.,
Santa Clara, CA, USA).
11.6. RNAseq Library Preparation
Double-stranded cDNA was synthesized from purified RNA using the SuperScript
Double-Stranded cDNA Synthesis kit (11917-010; Invitrogen, Carlsbad, CA, USA) following
manufacturer’s instructions. cDNA quality was assayed using the NanoDrop 2000 spectrophotometer
(Nanodrop Technologies) and the Agilent 2100 BioAnalyzer (Agilent Technologies Inc.) [73].
Sequencing libraries were constructed from 100ng of double-stranded cDNA from each sample
following using the KAPA HyperPlus library preparation kit (kk814, KAPA Biosystems, Boston, MA,
USA) with adaptors from BIOO Scientific NEXTFlex (514105, BIOO, Austin, TX, USA). Quality control
for fragment size distribution was done using the High Sensitivity kit (Agilent Technologies Inc.) while
library concentration was measured using the KAPA SYBR FAST qPCR kit Master Mix (2x) Universal
(kk4903; KAPA) on Bio-Rad CFX96 (Bio-Rad). Libraries were indexed at eight libraries per lane and
sequenced with PE150 on a HighSeq4000 at the California Institute for Quantitative Biosciences in the
Vincent J Coates Genomics Sequencing Lab (Berkeley, CA, USA).
11.7. Statistical Analysis for Differential Gene Expression
Prior to gene expression analysis the raw sequence reads were trimmed using Trimmomatic [74]
and aligned to the Ensembl GRCh38 human genome using HISAT2 [75] using an index downloaded
from the HISAT2 website on 11/22/16 (grch38_tran). Reads were aligned in paired-end mode with
soft clippings permitted. Paired-end reads that did not map to the human genome were separated
and subsequently aligned to the Listeria monocytogenes genome (GCA_000196035.1_ASM19603v1;
European Nucleotide Archive sample accession SAMEA3138329) using Bowtie2 [76]. All alignment
files output by HISAT2 and Bowtie2 were compressed using samtools [77]. This file was used for
differential expression analysis.
Gene counts were estimated using featureCounts in the Rsubread R package [78] and differential
gene expression analysis was performed in edgeR [79]. Gene counts were produced using the Ensembl
GRCh38.86.gtf annotation for human and the GCA_000196035.1_ASM19603v1.gtf annotation file for
L. monocytogenes. The gene count tables produced by featureCounts were separately entered in to
edgeR where normalization and differential expression were performed. Genes with counts per
million less than one and with expression in fewer than two samples per group were discarded.
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Reads were normalized using the library size. A design matrix was implemented based on treatment.
Because there were three or four biological replicates in each group, dispersion was estimated for each
treatment. Treatment groups contained pairwise comparisons so the edgeR exact test was used for
differential expression estimation. Significance was defined as adjusted p-value (FDR, this was done
using a Bonferroni correction) of less than or equal to 0.05.
No reads aligned to the L. monocytogenes genome from uninfected cells; therefore, no differential
expression analyses were performed for L. monocytogenes from these samples; differential expression
was performed only between L. monocytogenes infected samples.
Raw reads are publically available on the NCBI Sequence Read Archive (SRA). SRA identification
codes for each sample are available in Supplementary Table S1. Data and codes used for differential
expression analyses are available on Github (https://github.com/bartweimer/Listeria_prebiotic_
oligosaccharides).
11.8. Gene Expression Pathway Analysis
Host differential expression visualization and biological pathways were done using Ingenuity
Pathway Analysis software (IPA, Ingenuity Systems, QIAGEN, Redwood City, CA, USA) [80].
Significantly different signaling pathways were determined using IPA with a two-tailed Fisher’s
exact test (p ≤ 0.05) and canonical pathway enrichment.
Visualization of L. monocytogenes differential expression data was performed using BioCyc
SmartTables (Pathway Tools version 21.0, SRI International, Menlo Park). Gene set enrichment analysis
was done using a two-tailed Fisher’s exact test (p ≤ 0.05) with the Pathway Tools L. monocytogenes
strain EGD-e database version 21.0 [81] as described by Rivals et al. [82].
11.9. Transmission Electron Microscopy
TEM was performed at the UC Davis Electron Microscopy Core as previously described [73].
Cells were grown on Lab-Tek® Permanox Chamber 8-Well Slides from Electron Microscopy Sciences,
P.O. Box 550, 1560 Industry Road, Hatfield, PA, USA. Culture media was removed and at least 100 µL of
modified Karnovsky’s fixative (2.5% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.3) was added per well and fixed for a minimum of 1 h. The cells were washed in 0.1 M
phosphate buffer and secondarily fixed for 1 hour in freshly made 1% osmium tetroxide and 1.5%
potassium ferrocyanide in ddH20. Fixative was washed three times from the cells with cold ddH2O.
Dehydration follows through ascending concentrations of ethanol (30%, 50%, 70%, 95%, 100%) with
a minimum of 10 min in each and three changes of 100%. A 100% concentration of epon-araldite resin
lacking nadic methyl anhydride was added to each well and allowed to infiltrate overnight at room
temperature. The next day as much resin as possible was removed from each well. New resin was
added to fill the wells completely. Slides were polymerized at 70 ◦C. Once polymerized, area of interest
was chosen and cut to block size with a fine bladed (jewelers) saw. Sections were cut with a Leica UCT
ultramicrotome (Leica Ultracut UCT, Leica, Vienna, Austria) and stained with uranyl acetate and lead
citrate before viewing in the Talos L120C electron microscope at 80 KV. Images were acquired using
the fully integrated Ceta CBIOMOS camera (FEI/TheroBiomoscientific Company, Hillsboro, OR, USA,
made in Eindhoven, The Netherlands).
12. Conclusions
Studies to define the mechanism of prebiotic efficacy in minimizing infection risk have focused
on the secondary metabolites produced by intestinal bacteria and oligosaccharide blocking. In this
study, we demonstrated that host pretreatment with HMO led to a 50% decrease in L. monocytogenes
host association while pretreatment with Biomos led to a 150% increase in host association.
Biomos treatment repressed the expression of numerous catabolic pathways and influenced Listeria
glycosyl hydrolase activity on teichoic acid synthesis whereas HMO did not significantly modulate
L. monocytogenes gene expression. Host pretreatment with HMO potentiated a protective stress response
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with induction of UPR and eIF2 signaling, enabling enhanced bacterial clearance by the host and
subsequent host survival. In contrast, host pretreatment with Biomos hastened L. monocytogenes
vacuolar escape as evidenced by STING induction and by TEM and resulted in induction of host
autophagy. Altogether, this study revealed an unprecedented ability for prebiotic oligosaccharides to
influence host cellular signaling pathways and host and Listeria survival outcomes but they were not
due to blocking, rather colonic cell changes in the intrinsic response.
Supplementary Materials: The following are available online at www.mdpi.com/2076-0817/6/4/68/s1.
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